$233.75
$275.00
Selected size: 20mg
GLP-3R (Retatrutide)
SKU: GLP3R
Add items now. Sign in or create an account only when you proceed to checkout.
GLP-3R (Retatrutide, LY3437943) is a triple agonist research compound that simultaneously activates GLP-1, GIP, and glucagon receptors in laboratory studies.
Retatrutide functions as a triple agonist, simultaneously activating GLP-1, GIP, and glucagon receptors. Structural studies using cryo-electron microscopy have characterized how retatrutide binds to all three receptors. The glucagon receptor component increases energy expenditure in research models, providing metabolic effects beyond appetite suppression mechanisms observed in laboratory settings.
Research suggests that triple receptor agonism may provide superior metabolic effects compared to single or dual agonists in laboratory models. Phase 2 clinical trials have been conducted for research purposes. Phase 3 clinical trials are currently underway for type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and obesity research applications.
Researchers commonly order these items together
FOR RESEARCH USE ONLY
This product is intended strictly for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the FDA.
